Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 10.32 -0.01 (-0.1%) Market Cap: 604.08 Mil Enterprise Value: 432.49 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Phathom Pharmaceuticals Inc Corporate Analyst Meeting Transcript

Dec 14, 2020 / 06:00PM GMT
Release Date Price: $44.46 (-2.31%)
Todd P. Branning
Phathom Pharmaceuticals, Inc. - CFO

Good afternoon, and welcome to Phathom Pharmaceuticals Virtual Investor Day. Thank you for joining us. My name is Todd Branning, and I'm Phathom's Chief Financial Officer. We have a very exciting and robust agenda today.

As a housekeeping item before we begin the meeting, I want to make you aware that at the end of today's presentations, we will hold a Q&A session with our meeting presenters, including both our key opinion leaders and select members of Phathom's management team. You may submit questions at any time using the text box below your webcast window. We will try our best to answer as many questions as we can during the Q&A portion of the meeting. If you have questions after the meeting concludes, please send them to [email protected].

As a reminder, matters covered in today's presentation, including the accompanying slides, include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot